Cresset Asset Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.57M	Buy	4,332 +70	+2%	+$34.9K	0.01%	500
2025 Q4	$2.08M	Sell	4,262 -289	-6%	-$135K	0.01%	559
2025 Q3	$1.91M	Buy	4,551 +54	+1%	+$18.2K	0.01%	544
2025 Q2	$1.29M	Sell	4,497 -4,190	-48%	-$1.25M	0.01%	623
2025 Q1	$2.68M	Buy	8,687 +108	+1%	+$37K	0.01%	458
2024 Q4	$3.03M	Sell	8,579 -811	-9%	-$298K	0.01%	447
2024 Q3	$3.36M	Buy	9,390 +458	+5%	+$155K	0.01%	581
2024 Q2	$2.85M	Buy	8,932 +908	+11%	+$240K	0.01%	581
2024 Q1	$1.84M	Buy	8,024 +1,112	+16%	+$251K	0.01%	680
2023 Q4	$1.52M	Buy	6,912 +1,127	+19%	+$260K	0.01%	703
2023 Q3	$1.31M	Buy	5,785 +731	+14%	+$168K	0.01%	719
2023 Q2	$1.12M	Buy	+5,054	New	+$1.12M	0.01%	892
2022 Q1	–	Sell	-2,254	Closed	-$488K	–	1149
2021 Q4	$488K	Buy	2,254 +256	+13%	+$50.3K	﹤0.01%	708
2021 Q3	$368K	Buy	1,998 +20	+1%	+$3.94K	0.01%	748
2021 Q2	$355K	Sell	1,978 -1	-0.1%	-$190	0.01%	696
2021 Q1	$331K	Buy	+1,979	New	+$330K	0.01%	634
2019 Q2	–	Sell	-638	Closed	-$75K	–	1652
2019 Q1	$75K	Buy	638 +628	+6,280%	+$73.2K	﹤0.01%	655
2018 Q4	$1K	Buy	+10	New	+$1.16K	﹤0.01%	1613